References
1. Ishikawa, E., K. Tsuboi, T. Yamamoto, A. Muroi, T. Enomoto, S. Takano, A. Matsumura, and T. Ohno. 2007. Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients. Cancer Sci. 98:1226-1233.
2. Sakamoto, N., E. Ishikawa, T. Yamamoto, K. Satomi, K. Nakai, M. Sato, T. Enomoto, Y. Morishita, S. Takano, T. Ohno, K. Tsuboi, and A. Matsumura. 2011. Pathological changes after autologous formalin-fixed tumor vaccine therapy combined with temozolomide for glioblastoma -Three case reports-. Neurol. Med. Chir (Tokyo). 51:319-325.
3. Muragaki, Y., T. Maruyama, H. Iseki, M. Tanaka, C. Shinohara, K. Takakura, K. Tsuboi, T. Yamamoto, A. Matsumura, M. Matsutani, K. Karasawa, K. Shimada, N. Yamaguchi, Y. Nakazato, K. Sato, Y. Uemae, T. Ohno, Y. Okada, and T. Hori. 2011. Phase I / IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for initially-diagnosed glioblastoma. J. Neurosurg. 115:248-255.
4. Ishikawa, E., Y. Muragaki, T. Yamamoto, T. Maruyama, K. Tsuboi, S. Ikuta, K. Hashimoto, Y. Uemae, T. Ishihara, M. Matsuda, M. Matsutani, K. Karasawa, Y. Nakazato, T. Abe, T. Ohno, and A. Matsumura. 2014. Phase I/IIa trial of fractionated radiotherapy, temozolomide, and autologous formalin-fixed tumor vaccine for newly diagnosed glioblastoma. J. Neurosurg. 121:543-553.
5. Kuranishi, F., and T. Ohno. 2013. Eradication of breast cancer with bone metastasis by autologous formalin-fixed tumor vaccine (AFTV) combined with palliative radiation therapy and adjuvant chemotherapy: a case report. World J. Surg. Oncol. 11:127.
6. Kuranishi, F., Y. Imaoka, Y. Sumi, Y. Uemae, H. Yasuda-Kurihara, T. Ishihara, T. Miyazaki, and T. Ohno. 2018. Rate of clinical complete response for 1 year or more in bone-metastatic breast cancer after comprehensive treatments including autologous formalin-fixed tumor vaccine. Int. J. Breast Cancer, article ID 4879406.
7. Miyoshi, T., T. Kashiwabara, A. Asahi, T. Kataoka, T. Maruyama, R. Okada, Y. Uemae, and T. Ohno. 2017. Complete remission of chemo-refractory multiple-metastatic upper tract urothelial carcinoma by autologous formalin-fixed tumor vaccine. Clin. Case Rep. 5:1780-1784.
8. Inui, T., and T. Ohno. 2012. Autologous formalin-fixed tumor vaccine suppressed re-recurrence of HCV-related hepatocellular carcinoma following 29 unsuccessful treatments with extensive conventional therapy: A case report. World J. Surg. Oncol. 10:144.
9. Kawashima, I., Y. Kawashima, Y. Matsuoka, K. Fujise, H. Sakai, M. Takahashi, T. Yoshikawa, T. Nakatsura, T. Ishihara, and T. Ohno. 2015. Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3. Clin. Case Rep. 3:444-447.
10. Todoroki, T., T. Kondo, S. Sugahara, Y. Morishita, K. Mori, and T. Ohno. 2011. Long-term survivor of relapsed MFH on the thigh treated with autologous formalin-fixed tumor vaccine (AFTV) combined with limb-sparing surgery and radiotherapy. World J. Surg. Oncol. 9:96.
11. Chen, J. T., and T. Ohno. 2015. Recurrent peritoneal serous carcinoma that was unmanageable with paclitaxel–carboplatin therapy responded to autologous formalin-fixed tumor vaccine. Clin. Case Rep.